173,97 $
2,27 % vorgestern
Nasdaq, 24. Oktober, 22:00 Uhr
ISIN
US74006W1080
Symbol
PRAX
Berichte

Praxis Precision Medicines Inc Aktie News

Positiv
The Motley Fool
etwa 14 Stunden alt
Shares of Praxis Precision Medicine shot 251% higher in a little over a week during the month of October. Praxis Precision Medicine announced successful results from a phase 3 trial with its lead candidate.
Neutral
GlobeNewsWire
10 Tage alt
BOSTON, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced the pricing of its underwritten public offering of 3,025,480 shares of its common ...
Neutral
Seeking Alpha
10 Tage alt
Praxis Precision Medicines, Inc. (NASDAQ:PRAX ) Discusses Essential3 Topline Results and Next Steps in Essential Tremor Program October 16, 2025 8:00 AM EDT Company Participants Marcio Souza - President, CEO & Director Conference Call Participants Daniel Ferry - Lifesci Advisors, LLC Ritu Baral - TD Cowen, Research Division Yasmeen Rahimi - Piper Sandler & Co., Research Division Joon Lee - Trui...
Neutral
GlobeNewsWire
10 Tage alt
BOSTON, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced a proposed public offering of its common stock and, in lieu of common stock to cer...
Positiv
Market Watch
10 Tage alt
Shares of Praxis Precision Medicines have hit their highest intraday level since March 2022.
Positiv
Invezz
10 Tage alt
Praxis Precision Medicines (NASDAQ: PRAX stock) saw a skyrocketing 235% rally on Thursday after announcing positive topline results from two pivotal Phase 3 studies of ulixacaltamide for essential tremor, a common movement disorder.
Positiv
Investors Business Daily
10 Tage alt
Shares of Praxis Precision Medicines skyrocketed more than 200% Thursday on "groundbreaking" test results for an essential tremor treatment.
Positiv
Reuters
10 Tage alt
Praxis Precision Medicines said on Thursday its experimental drug for movement disorder helped improve daily functioning in patients in two late-stage trials.

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen